The Centers for Disease Control and Prevention (CDC) recommends using nucleic-acid amplification tests (NAAT) when testing female patients under the age of 25 for Chlamydia trachomatis.
Although the Centers for Disease Control and Prevention (CDC) recommends using nucleic-acid amplification tests (NAAT), many clinicians still use urine NAAT to test for Chlamydia trachomatis in sexually active female patients under the age of 25.
A new report explored whether an improvement program could be beneficial in increasing the number of clinicians using the vaginal swab NAAT. The study ultimately discovered that the quality improvement program did, in fact, lead to significant increase in the use of vaginal swabs to test for C. trachomatis.
For details on this study and its findings, visit Contemporary Pediatrics.
FDA approves Visby’s test for at-home STI identification
Published: March 28th 2025 | Updated: March 28th 2025The FDA has approved Visby Medical’s at-home sexually transmitted infection test, allowing women to screen for chlamydia, gonorrhea, and trichomoniasis without a prescription.
Read More
In this episode of Pap Talk, Gloria Bachmann, MD, MSc, breaks down what it means to be a health care provider for incarcerated individuals, and explores the specific challenges women and their providers face during and after incarceration. Joined by sexual health expert Michael Krychman, MD, Bachmann also discusses trauma-informed care and how providers can get informed.
Listen